|Articles|September 1, 2016
Value-Based Decisions in Diabetes: Evaluating Safety, Efficacy, and Costs of Therapeutic Alternatives
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants
3
Dermatology Practices Absorb Rising Prior Authorization Costs
4
Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types
5